Selvi Attorney Partnership has represented the buyer on the acquisition of the shares representing the %100 of the share capital of Biofarma İlaç Sanayi ve Ticaret A.Ş.

This landmark transaction paves the way for a well-known Turkish pharmaceutical company with a significant market presence to embark on its next stage of growth and transformation.

The deal team was led by Çağdaş Selvi and Neslihan Tuına Saraçgil Aksoy, with contributions of Emirhan Özdinçer and Helin Güler.